Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications

被引:10
|
作者
Friberger, Ida [1 ]
Jussing, Emma [2 ,3 ]
Han, Jinming [1 ,4 ]
Goos, Jeroen A. C. M. [1 ,2 ,3 ]
Siikanen, Jonathan [2 ,5 ]
Kaipe, Helen [6 ,7 ]
Lambert, Melanie [8 ]
Harris, Robert A. [1 ,4 ]
Samen, Erik [2 ,3 ]
Carlsten, Mattias [8 ,9 ]
Holmin, Staffan [1 ,10 ]
Tran, Thuy A. [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiopharm, Stockholm, Sweden
[4] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
[8] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[9] Karolinska Univ Hosp, Ctr Cell Therapy & Allogene Stem Cell Transplanta, Stockholm, Sweden
[10] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Cell labelling; Cell tracking; Zr-89; Oxine; Deferoxamine; PET; Imaging; DONOR LYMPHOCYTE INFUSION; DECIDUAL STROMAL CELLS; TRACKING; LEUKOCYTES; PET; CYTOTOXICITY; LEUKEMIA; RELAPSE;
D O I
10.1007/s11307-021-01622-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [Zr-89]Zr-oxine (8-hydroxyquinoline) and [Zr-89]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. Procedures Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [Zr-89]Zr-oxine or [Zr-89]Zr-DFO-NCS. The cellular retention of Zr-89 and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. Results The optimised synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. Zr-89 labelling neither significantly affected the cell viability (cell viability loss was in the range of 1-8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells' proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. Conclusions Our study demonstrates that [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS are equally effective in cell labelling. However, [Zr-89]Zr-oxine was superior to [Zr-89]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency.
引用
收藏
页码:952 / 962
页数:11
相关论文
共 50 条
  • [11] Biodistribution of Mesenchymal Stromal Cells Labeled with [89Zr]Zr-Oxine in Local Radiation Injuries in Laboratory Animals
    Astrelina, Tatiana A.
    Brunchukov, Vitaliy A.
    Kodina, Galina E.
    Bubenshchikov, Viktor B.
    Larenkov, Anton A.
    Lunev, Aleksandr S.
    Petrosova, Kristina A.
    Rastorgueva, Anna A.
    Kobzeva, Irina V.
    Usupzhanova, Daria Y.
    Nikitina, Victoria A.
    Malsagova, Kristina A.
    Kulikova, Ludmila I.
    Samoilov, Alexander S.
    Pustovoyt, Vasiliy I.
    MOLECULES, 2023, 28 (20):
  • [12] Optimization and comparison of cell labeling strategy with [89Zr]Zr-complex for cell trafficking
    Kim, M.
    Kim, D.
    Lee, S.
    Kim, S.
    Soh, H.
    Ryu, J.
    Oh, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S671 - S671
  • [13] Synthesis of [89Zr]Zr-DFO-PEG5-Tz and in vivo evaluation of bioorthogonally labeled antibody
    Lumen, Dave
    Vugts, Danielle
    Lang, Pauline
    Chomet, Marion
    Verlaan, Mariska
    Vos, Ricardo
    Windhorst, Albert
    Airaksinen, Anu
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S483 - S484
  • [14] [89Zr(oxinate)4] for cell tracking using PET
    Charoenphun, Putthiporn
    Meszaros, Levente
    Chuamsaamarkkee, Krisanat
    Sharif-Paghaleh, Ehsan
    Ballinger, James
    Mullen, Gregory
    Blower, Philip
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [15] A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3
    Man, Francis
    Khan, Azalea A.
    Carrascal-Minino, Amaia
    Blower, Philip J.
    de Rosales, Rafael T. M.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 90-91 : 31 - 40
  • [16] Novel 89Zr cell-labeling method for PET imaging of cell trafficking
    Bansal, Aditya
    Pandey, Mukesh
    Demirhan, Yunus
    Nesbitt, Jonathan
    Crespo-Diaz, Ruben
    Terzic, Andre
    Behfar, Atta
    DeGrado, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [17] Production of [89Zr]Oxinate4 and cell radiolabeling for human use
    Massicano, Adriana V. F.
    Bartels, Jennifer L.
    Jeffers, Charlotte D.
    Crenshaw, Bryant K.
    Houson, Hailey
    Mueller, Christina
    Younger, Jarred W.
    Knapp, Paul
    McConathy, Jonathan E.
    Lapi, Suzanne E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2021, 64 (05): : 209 - 216
  • [18] Production of [89Zr]Oxinate4 and cell labelingfor human use
    Massicano, Adriana
    Jeffers, Charlotte
    Bartels, Jennifer
    Houson, Hailey
    Lapi, Suzanne
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [19] Evaluation of the in vitro and in vivo characteristics of the novel 89Zr octacoordinated chelator DFO-cyclo* compared to the hexacoordinated DFO
    Raave, R.
    Sandker, G.
    Heskamp, S.
    Boerman, O.
    Rijpkema, M.
    Mangin, F.
    Meyer, M.
    Chambron, J.
    Moreau, M.
    Bernhard, C.
    Goncalves, V.
    Denat, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S221 - S221
  • [20] Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET
    Raave, Rene
    Sandker, Gerwin
    Adumeau, Pierre
    Jacobsen, Christian Borch
    Mangin, Floriane
    Meyer, Michel
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Dubois, Adrien
    Goncalves, Victor
    Gustafsson, Magnus
    Rijpkema, Mark
    Boerman, Otto
    Chambron, Jean-Claude
    Heskamp, Sandra
    Denat, Franck
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1966 - 1977